Skip to content

Toward Thriving: A Set of Reflective Tools to Empower Chronic Pain Patients and Help Them Envision a Personal Path to Thriving.

Toward Thriving: A Set of Reflective Tools to Empower Chronic Pain Patients and Help Them Envision a Personal Path to Thriving.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05847881
Enrollment
23
Registered
2023-05-08
Start date
2023-04-25
Completion date
2023-07-25
Last updated
2024-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Keywords

Positive psychology intervention

Brief summary

The purpose of this study is to introduce and test the usefulness of a reflective process meant to empower people with chronic pain and help support participant's resiliency and thriving. The study team hypothesizes that: -Greater or equal to 80 percent of participants will report that the intervention was relatively easy to understand after orientation, low burden, potentially effective, and will have completed at least 2 of the 3 reflective tools.

Interventions

BEHAVIORALSelf-guided at home activities

After the kick-off meeting participants will complete the cultural probe kit for 3 weeks. This kit is a design research tool, to prompt participants to document, map, journal, and reflect on various aspects of daily lives. Following this, participants will attend a facilitated workshop and then complete the next at-home kits.

Sponsors

National Center for Advancing Translational Sciences (NCATS)
CollaboratorNIH
University of Michigan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Persistent or recurrent pain lasting longer than 3 months * Able to read and write English

Exclusion criteria

* Cancer (History of any bone-related cancer or cancer that metastasized to the bone; Currently in treatment for any cancer or plan to start cancer treatment in the next 12 months; History of any cancer treatment in the last 24 months) * Active substance abuse * Uncontrolled depression or psychosis * Visual or hearing difficulties that would preclude participation * Individuals started receiving disability or compensation within the past year, or currently involved in litigation * Current/planned (in the next 2 years) enrollment in another study of a device or investigational drug that would interfere with this study, this may include participation in a blinded trial. * Any other diseases or conditions that would make a patient unsuitable for study participation as determined by the site principal investigators. This would include but not be limited to severe psychiatric disorders, active suicidal ideations or history of suicide attempts, and an uncontrolled drug and/or alcohol addiction)

Design outcomes

Primary

MeasureTime frameDescription
Participants Engaged in the InterventionsBaseline (T1) to Exit Interview (T4), up to 68 daysThe timepoints were as follows: consent and survey (T1), Kick-off Meeting (T2), Workshop (T3), and Exit Interview (T4). Participants had to attend the Kick-off Meeting (T2) to be considered engaged in the intervention. Participants who did not attend the Kick-off Meeting (T2) were withdrawn. Participants who did not attend the Workshop (T3) could still attend the Exit Interview (T4).

Secondary

MeasureTime frameDescription
Patient Global Impression of Change (PGIC) at T4 Exit Interviewat T4 Exit Interview, up to 68 daysParticipants completed the PGIC at the exit interview. The PGIC had one question with seven options ranging from -3 to 3: very much worse (-3), much worse (-2), minimally worse (-1), no change (0), minimally improved (1), much improved (2), very much improved (3). A higher score indicated greater improvement since the start of the study.
Change in Pain Interference Based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 Version 2.0 Between Baseline (t1) and Approximately 68 Days (t4 Exit Interview)Up to 68 daysThere were 4 questions in this questionnaire. For each question, participants selected one of five options, ranging from not at all (1) to very much (5). Total scores ranged from 4 to 20 points, where higher scores indicated more pain interference. Since this survey was discussing the change in the pain interference, a negative score indicated less pain interfering with day-to-day activities.The change betwen the baseline (T1 and Exit Interview (t4) is reported.

Countries

United States

Participant flow

Participants by arm

ArmCount
Reflective Process Group
Self-guided at home activities: After the kick-off meeting participants will complete the cultural probe kit for 3 weeks. This kit is a design research tool, to prompt participants to document, map, journal, and reflect on various aspects of daily lives. Following this, participants will attend a facilitated workshop and then complete the next at-home kits.
23
Total23

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyPrincipal Investigator Decision8
Overall StudyWithdrawal by Subject2

Baseline characteristics

CharacteristicReflective Process Group
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
5 Participants
Age, Categorical
Between 18 and 65 years
18 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
18 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
4 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
Race (NIH/OMB)
White
16 Participants
Region of Enrollment
United States
23 Participants
Sex: Female, Male
Female
16 Participants
Sex: Female, Male
Male
7 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 23
other
Total, other adverse events
0 / 23
serious
Total, serious adverse events
0 / 23

Outcome results

Primary

Participants Engaged in the Interventions

The timepoints were as follows: consent and survey (T1), Kick-off Meeting (T2), Workshop (T3), and Exit Interview (T4). Participants had to attend the Kick-off Meeting (T2) to be considered engaged in the intervention. Participants who did not attend the Kick-off Meeting (T2) were withdrawn. Participants who did not attend the Workshop (T3) could still attend the Exit Interview (T4).

Time frame: Baseline (T1) to Exit Interview (T4), up to 68 days

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Reflective Process GroupParticipants Engaged in the InterventionsConsent and Survey (T1)23 Participants
Reflective Process GroupParticipants Engaged in the InterventionsKick off Meeting (T2)14 Participants
Reflective Process GroupParticipants Engaged in the InterventionsWorkshop (T3)12 Participants
Reflective Process GroupParticipants Engaged in the InterventionsExit Interview13 Participants
Secondary

Change in Pain Interference Based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 Version 2.0 Between Baseline (t1) and Approximately 68 Days (t4 Exit Interview)

There were 4 questions in this questionnaire. For each question, participants selected one of five options, ranging from not at all (1) to very much (5). Total scores ranged from 4 to 20 points, where higher scores indicated more pain interference. Since this survey was discussing the change in the pain interference, a negative score indicated less pain interfering with day-to-day activities.The change betwen the baseline (T1 and Exit Interview (t4) is reported.

Time frame: Up to 68 days

Population: The difference between the number of participants at baseline and in the results here is because of participant attrition and incomplete responses from participants that could not be included in the final results data.

ArmMeasureGroupValue (MEAN)Dispersion
Reflective Process GroupChange in Pain Interference Based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 Version 2.0 Between Baseline (t1) and Approximately 68 Days (t4 Exit Interview)Baseline13.833 score on a scaleStandard Deviation 2.791
Reflective Process GroupChange in Pain Interference Based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 Version 2.0 Between Baseline (t1) and Approximately 68 Days (t4 Exit Interview)Change from Baseline to Exit Interview-1.583 score on a scaleStandard Deviation 3.753
Secondary

Patient Global Impression of Change (PGIC) at T4 Exit Interview

Participants completed the PGIC at the exit interview. The PGIC had one question with seven options ranging from -3 to 3: very much worse (-3), much worse (-2), minimally worse (-1), no change (0), minimally improved (1), much improved (2), very much improved (3). A higher score indicated greater improvement since the start of the study.

Time frame: at T4 Exit Interview, up to 68 days

Population: Results reflect the participants who attended the T4 exit interview and completed the PGIC. Of the 13 participants who attended the exit interview, 1 did not complete the PGIC.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Reflective Process GroupPatient Global Impression of Change (PGIC) at T4 Exit InterviewVery much improved0 Participants
Reflective Process GroupPatient Global Impression of Change (PGIC) at T4 Exit InterviewMuch Improved4 Participants
Reflective Process GroupPatient Global Impression of Change (PGIC) at T4 Exit InterviewMinimally Improved5 Participants
Reflective Process GroupPatient Global Impression of Change (PGIC) at T4 Exit InterviewNo change2 Participants
Reflective Process GroupPatient Global Impression of Change (PGIC) at T4 Exit InterviewMinimally worse0 Participants
Reflective Process GroupPatient Global Impression of Change (PGIC) at T4 Exit InterviewMuch worse1 Participants
Reflective Process GroupPatient Global Impression of Change (PGIC) at T4 Exit InterviewVery much worse0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026